Apogee Therapeutics (APGE) Change in Account Payables (2022 - 2026)
Apogee Therapeutics (APGE) reported Change in Account Payables of $16000.0 for Q1 2026, down 98.84% year-over-year from $1.4 million in Q1 2025, and down 98.11% on a QoQ basis from $845000.0 in Q4 2025.
Apogee Therapeutics (APGE) has 5 years of Change in Account Payables data on file, last reported at $16000.0 in Q1 2026.
- Quarterly Change in Account Payables fell 98.84% year-over-year to $16000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.2 million (up 34.95% YoY) and the FY2025 annual result came in at $150000.0, up 113.99% from the prior year.
- Change in Account Payables declined to $16000.0 in Q1 2026 per APGE's latest filing, from $845000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $9.9 million in Q2 2023 and bottomed at -$9.8 million in Q3 2023.
- The 5-year median for Change in Account Payables is $477000.0 (2023), against an average of $733.33.
- The widest annual swing landed in 2023, when Change in Account Payables slumped 805.57%; it then jumped 352.62% in 2024.
- Tracing APGE's Change in Account Payables over 5 years: stood at $382000.0 in 2022, then soared by 171.2% to $1.0 million in 2023, then slumped by 210.52% to -$1.1 million in 2024, then surged by 173.8% to $845000.0 in 2025, then sank by 98.11% to $16000.0 in 2026.
- Per Business Quant, the three latest APGE Change in Account Payables figures stand at $16000.0 (Q1 2026), $845000.0 (Q4 2025), and -$5.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Apogee Therapeutics | 5.53 Bn | 4.47 Bn | - | 16,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16,000.00 |
| Mar 31, 2026 | 16,000.00 |
| Dec 31, 2025 | 845,000.00 |
| Dec 31, 2025 | 845,000.00 |
| Sep 30, 2025 | -5.30 Mn |
| Sep 30, 2025 | -5.30 Mn |
| Jun 30, 2025 | 3.23 Mn |
| Jun 30, 2025 | 3.23 Mn |
| Mar 31, 2025 | 1.37 Mn |
| Mar 31, 2025 | 1.37 Mn |
| Dec 31, 2024 | -1.15 Mn |
| Dec 31, 2024 | -1.15 Mn |
| Sep 30, 2024 | -3.31 Mn |
| Sep 30, 2024 | -3.31 Mn |
| Jun 30, 2024 | 1.23 Mn |
| Jun 30, 2024 | 1.23 Mn |
| Mar 31, 2024 | 2.16 Mn |
| Mar 31, 2024 | 2.16 Mn |
| Dec 31, 2023 | 1.04 Mn |
| Dec 31, 2023 | 1.04 Mn |
| Sep 30, 2023 | -9.76 Mn |
| Sep 30, 2023 | -9.76 Mn |
| Jun 30, 2023 | 9.86 Mn |
| Jun 30, 2023 | 9.86 Mn |
| Mar 31, 2023 | 477,000.00 |
| Mar 31, 2023 | 477,000.00 |
| Dec 31, 2022 | 382,000.00 |
| Dec 31, 2022 | 382,000.00 |
| Sep 30, 2022 | -1.08 Mn |
| Sep 30, 2022 | -1.08 Mn |